These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 7805226)
1. Beta-adrenergic blocking property of dl-sotalol maintains class III efficacy in guinea pig ventricular muscle after isoproterenol. Groh WJ; Gibson KJ; McAnulty JH; Maylie JG Circulation; 1995 Jan; 91(2):262-4. PubMed ID: 7805226 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of d, l-sotalol and d-sotalol on isoproterenol-increased delayed rectifier outward potassium current in guinea pig single ventricular myocytes. Yao X; Yannoulis NC; Kiehn J; Lu Z; Zhao H; Brachmann J J Tongji Med Univ; 1998; 18(1):13-7. PubMed ID: 10806794 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of the new class III antiarrhythmic agents almokalant, E-4031 and D-sotalol, and of quinidine, on delayed rectifier currents in guinea pig ventricular myocytes. Wettwer E; Grundke M; Ravens U Cardiovasc Res; 1992 Nov; 26(11):1145-52. PubMed ID: 1291093 [TBL] [Abstract][Full Text] [Related]
4. Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia. MacKenzie I; Saville VL; Waterfall JF Br J Pharmacol; 1993 Oct; 110(2):531-8. PubMed ID: 8242227 [TBL] [Abstract][Full Text] [Related]
5. Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents. Vanoli E; Priori SG; Nakagawa H; Hirao K; Napolitano C; Diehl L; Lazzara R; Schwartz PJ J Am Coll Cardiol; 1995 Jun; 25(7):1609-14. PubMed ID: 7759713 [TBL] [Abstract][Full Text] [Related]
6. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs. Sen L; Cui G; Sakaguchi Y; Singh BN J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614 [TBL] [Abstract][Full Text] [Related]
7. Block of gating currents related to K+ channels as a mechanism of action of clofilium and d-sotalol in isolated guinea-pig ventricular heart cells. Malécot CO; Argibay JA Br J Pharmacol; 1999 Sep; 128(2):301-12. PubMed ID: 10510439 [TBL] [Abstract][Full Text] [Related]
8. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans. Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666 [TBL] [Abstract][Full Text] [Related]
9. Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions. Holubarsch C; Schneider R; Pieske B; Ruf T; Hasenfuss G; Fraedrich G; Posival H; Just H Circulation; 1995 Nov; 92(10):2904-10. PubMed ID: 7586258 [TBL] [Abstract][Full Text] [Related]
10. Class III antiarrhythmic action of d-sotalol during hypothermia. Bjørnstad H; Tande PM; Refsum H Am Heart J; 1991 May; 121(5):1429-36. PubMed ID: 2017975 [TBL] [Abstract][Full Text] [Related]
11. Comparative beta-blocking activities and electrophysiologic actions of racemic sotalol and its optical isomers in anesthetized dogs. Gomoll AW; Bartek MJ Eur J Pharmacol; 1986 Dec; 132(2-3):123-35. PubMed ID: 2880732 [TBL] [Abstract][Full Text] [Related]
12. Differences in the Effects of d- and dl-Sotalol on Isolated Human Ventricular Muscle: Electromechanical Activity After Beta-Adrenoceptor Stimulation. Lathrop DA; Varró A; Nánási PP; Bódi I; Takyi E; Pankucsi C J Cardiovasc Pharmacol Ther; 1996 Jan; 1(1):65-74. PubMed ID: 10684401 [TBL] [Abstract][Full Text] [Related]
13. The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization. Varro A; Baláti B; Iost N; Takács J; Virág L; Lathrop DA; Csaba L; Tálosi L; Papp JG J Physiol; 2000 Feb; 523 Pt 1(Pt 1):67-81. PubMed ID: 10675203 [TBL] [Abstract][Full Text] [Related]
15. Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers. Carmeliet E J Pharmacol Exp Ther; 1985 Mar; 232(3):817-25. PubMed ID: 3973830 [TBL] [Abstract][Full Text] [Related]
16. Subsidiary class III effects of beta blockers? A comparison of atenolol, metoprolol, nadolol, oxprenolol and sotalol. Manley BS; Alexopoulos D; Robinson GJ; Cobbe SM Cardiovasc Res; 1986 Oct; 20(10):705-9. PubMed ID: 2878723 [TBL] [Abstract][Full Text] [Related]
17. Effects of N-acetylprocainamide and sotalol on ion currents in isolated guinea-pig ventricular myocytes. Komeichi K; Tohse N; Nakaya H; Shimizu M; Zhu MY; Kanno M Eur J Pharmacol; 1990 Oct; 187(3):313-22. PubMed ID: 1705889 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiological characterization of the class III activity of sotalol and its enantiomers. New interpretation of use-dependent effects. Hafner D; Berger F; Borchard U; Kullmann A; Scherlitz A Arzneimittelforschung; 1988 Feb; 38(2):231-6. PubMed ID: 3370070 [TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits. Baczkó I; El-Reyani NE; Farkas A; Virág L; Iost N; Leprán I; Mátyus P; Varró A; Papp JG Eur J Pharmacol; 2000 Sep; 404(1-2):181-90. PubMed ID: 10980278 [TBL] [Abstract][Full Text] [Related]
20. Frequency-dependent electrophysiologic effects of d,l-sotalol and quinidine and modulation by beta-adrenergic stimulation. Sager PT; Behboodikhah M J Cardiovasc Electrophysiol; 1996 Feb; 7(2):102-12. PubMed ID: 8853020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]